A Study Using fMRI Imaging to Evaluate the Effect of NKTR-181 on Brain Activity in Healthy, Non-physically Dependent Recreational Opioid Users.

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Moderate to Severe Chronic Pain

In brief

The main purpose of this study is to evaluate the effect of NKTR-181 on brain activity in healthy, non-physically dependent recreational opioid users. This study will last about 88 days for each participant.

Key facts

Study ID

NCT03802227

Run by

Nektar Therapeutics

People needed

8

Starts

2018-10-22

Expected to finish

2020-01-03

Last updated by the study team

2021-07-08

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

Where it is running

• Investigator Site - Richmond — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.